Plus Therapeutics, Inc. (PSTV)

NASDAQ: PSTV · IEX Real-Time Price · USD

1.740

+0.010 (0.58%)

At close: Jul 19, 2024, 4:00 PM

1.760

+0.020 (1.15%)

Pre-market: Jul 22, 2024, 7:00 AM EDT

Plus Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1998
Revenue	6.08	4.91	0.22	0	0.3	7	Upgrade
Revenue Growth (YoY)	733.42%	2093.30%	-	-	-95.67%	134.60%	Upgrade
Gross Profit	6.08	4.91	0.22	0	0.3	7	Upgrade
Selling, General & Admin	8.51	8.54	10.24	6.85	6.41	5.29	Upgrade
Research & Development	9.47	9.69	9.7	5.32	2.7	5.37	Upgrade
Other Operating Expenses	0	0	0	0.32	0.78	0	Upgrade
Operating Expenses	17.98	18.23	19.94	12.49	9.89	10.66	Upgrade
Operating Income	-11.9	-13.32	-19.71	-12.49	-9.58	-3.66	Upgrade
Interest Expense / Income	0.3	0.4	0.71	0.93	1.11	1.86	Upgrade
Other Expense / Income	-0.42	-0.4	-0.15	-0.03	-2.45	5.38	Upgrade
Pretax Income	-11.77	-13.32	-20.28	-13.4	-8.24	-10.89	Upgrade
Net Income	-11.77	-13.32	-20.28	-13.4	-8.24	-10.89	Upgrade
Preferred Dividends	0	0	0	0	0	0.55	Upgrade
Net Income Common	-11.77	-13.32	-20.28	-13.4	-8.24	-11.44	Upgrade
Shares Outstanding (Basic)	4	3	2	1	0	0	Upgrade
Shares Outstanding (Diluted)	4	3	2	1	0	0	Upgrade
Shares Change	86.28%	79.45%	117.07%	173.03%	219.93%	696.08%	Upgrade
EPS (Basic)	-3.04	-4.24	-11.58	-16.64	-27.89	-123.99	Upgrade
EPS (Diluted)	-3.04	-4.24	-11.58	-16.64	-27.89	-123.99	Upgrade
Free Cash Flow	-11.67	-13.01	-13.48	-10.36	-8.53	-5.97	Upgrade
Free Cash Flow Per Share	-2.70	-4.14	-7.70	-12.85	-28.87	-64.70	Upgrade
Gross Margin	100.00%	100.00%	100.00%	-	100.00%	100.00%	Upgrade
Operating Margin	-195.60%	-271.14%	-8800.00%	-	-3163.04%	-52.26%	Upgrade
Profit Margin	-193.49%	-271.04%	-9051.34%	-	-2719.80%	-163.49%	Upgrade
Free Cash Flow Margin	-191.88%	-264.83%	-6018.30%	-	-2814.19%	-85.35%	Upgrade
EBITDA	-10.73	-12.18	-18.85	-12.05	-6.77	-8.12	Upgrade
EBITDA Margin	-176.41%	-247.83%	-8416.07%	-	-2232.67%	-116.09%	Upgrade
Depreciation & Amortization	0.74	0.75	0.71	0.42	0.37	0.91	Upgrade
EBIT	-11.48	-12.92	-19.56	-12.47	-7.13	-9.03	Upgrade
EBIT Margin	-188.64%	-263.00%	-8733.93%	-	-2354.46%	-129.07%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).